Literature DB >> 18555915

Why rare diseases are an important medical and social issue.

Arrigo Schieppati1, Jan-Inge Henter, Erica Daina, Anita Aperia.   

Abstract

Mesh：

Year:  2008        PMID： 18555915     DOI： 10.1016/S0140-6736(08)60872-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  151 in total

Review 1.  Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years.

Authors:  M Miles Braun; Sheiren Farag-El-Massah; Kui Xu; Timothy R Coté
Journal:  Nat Rev Drug Discov       Date:  2010-06-07       Impact factor: 84.694

2.  Children and Adults With Rare Diseases Need Innovative Medical Devices.

Authors:  Vasum Peiris; Kui Xu; Heather L Agler; Eric A Chen; Rashmi Gopal-Srivastava; Brian M Lappin; Debra Y Lewis; Gayatri R Rao
Journal:  J Med Device       Date:  2018-07-13       Impact factor: 0.582

3.  A cybernetic eye for rare disease.

Authors:  Qian Wang; Dinggang Shen
Journal:  Nat Biomed Eng       Date:  2017-02-10       Impact factor: 25.671

4.  Orphan drug development is not taking off.

Authors:  Roberta Joppi; Vittorio Bertele; Silvio Garattini
Journal:  Br J Clin Pharmacol       Date:  2009-01-21       Impact factor: 4.335

Review 5.  Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery.

Authors:  Michael R Barnes; Lee Harland; Steven M Foord; Matthew D Hall; Ian Dix; Scott Thomas; Bryn I Williams-Jones; Cory R Brouwer
Journal:  Nat Rev Drug Discov       Date:  2009-07-17       Impact factor: 84.694

6.  The orphan disease networks.

Authors:  Minlu Zhang; Cheng Zhu; Alexis Jacomy; Long J Lu; Anil G Jegga
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

7.  Access to orphan drugs despite poor quality of clinical evidence.

Authors:  Alain G Dupont; Philippe B Van Wilder
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

Review 8.  Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 9.  Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System.

Authors:  Joshua G Hunsberger; Anastasia G Efthymiou; Nasir Malik; Mamta Behl; Ivy L Mead; Xianmin Zeng; Anton Simeonov; Mahendra Rao
Journal:  Stem Cells Dev       Date:  2015-04-20       Impact factor: 3.272

10.  Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms.

Authors:  Martino Ruggieri; Andrea D Praticò; Agostino Serra; Luigi Maiolino; Salvatore Cocuzza; Rosario Caltabiano; Agata Polizzi
Journal:  Childs Nerv Syst       Date:  2016-09-26       Impact factor: 1.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.